Avery Dennison Corp., of Glendale, Calif., said its medical businesses – Vancive Medical Technologies and Finesse Medical Ltd. – have been rebranded as Avery Dennison Medical. The company is a supplier and partner for medical device manufacturers and converters.
Mississauga, Ontario-based Baylis Medical Company Inc. reported the first Arctic Front Advance Cryoballoon procedures performed using the Versacross Transseptal Solution. The Versacross solution is available in J-Tip and Pigtail wire configurations. The device is expected to launch early next year.
Capillus LLC, of Miami, has undergone a name change and now is called Curallux LLC.
Carlisle Companies Inc., of Scottsdale, Ariz., completed the purchase of Providien LLC, of San Diego. Providien provides solutions for medical technology original equipment manufacturers, including contract manufacturing, precision machining and metals, thermoforming and injection molding.
New York-based Massive Bio, which focuses on artificial intelligence-based oncology clinical trial enrollment, and Research Triangle Park, N.C.-based The American Sexual Health Association, which aims to advance the health of communities by improving awareness in sexual health, have formed a partnership to promote targeted clinical trials to cervical cancer patients.
Myriad Genetics Inc., of Salt Lake City, said that the American College of Rheumatology has included the Vectra test in its list of recommended disease activity measures for patients with rheumatoid arthritis. The new recommendations were published in the journal Arthritis Care & Research.
Predictive Oncology Inc., of Minneapolis, entered a $15 million common stock purchase and registration rights agreement with Oasis Capital LLC, of San Juan, Puerto Rico, over a 36-month period. The equity line is intended to provide capital and take advantage of milestones to advance Predictive Oncology’s Cancer Quest 2020 project.
Rheonix Inc., of Ithaca, N.Y., said that it has submitted a 510(k) for FDA clearance of its Rheonix STI Triplex assay, a polymerase chain reaction-based test for the simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis, along with the Rheonix Encompass MDx Workstation. The filing also seeks clearance of the Rheonix Urine Specimen Collection Kit and Rheonix Swab Specimen Collection Kit. The company conducted a multicenter trial with U.S. collection and testing sites to support the submission.
Bridgewater, N.J.-based Sanofi reported an enterprise-wide collaboration with New York-based Aetion Inc. to integrate Sanofi’s real-world data platform, Darwin, with the Aetion Evidence platform. By combining the platforms, Sanofi aims to enhance its capabilities in conducting regulatory-grade studies.
Soleo Health, of McKinney, Texas, has acquired Dayton, Ohio-based Paragon Infusion Therapy’s pharmacy business for an undisclosed sum. The purchase expands Soleo’s national footprint of 20 pharmacies nationwide and strengthens its Midwest presence.
Horsham, Pa.-based Strata Skin Sciences Inc. reported that it has regained compliance with Nasdaq listing requirements, eliminating the need for a scheduled hearing before the Nasdaq Hearings Panel. The company will continue to trade on Nasdaq under the symbol SSKN.
Houston-based United Imaging-North America, a subsidiary of Shanghai United Imaging Healthcare Co. Ltd., of China, is teaming up with Shared Medical Services Inc. (SMS), of Grove, Wis., to launch a mobile digital positron emission tomography/computed tomography unit in the U.S. SMS operates a fleet of diagnosis imaging vehicles, one of which will be fully outfitted with United Imaging’s new uMI 550 digital PET/CT imaging technology.